These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38781873)

  • 1. Cytokine and chemokine profiles in the sera of COVID-19 patients with different stages of severity.
    Bourhis M; Idir A; Machraoui S; Hachimi A; Elouardi Y; Jamil O; Khallouki M; Zahlane K; Guennouni M; Hazime R; Essaadouni L; Lourhlam B; Ennaji MM; Mouse HA; Admou B; Zyad A
    Cytokine; 2024 Aug; 180():156653. PubMed ID: 38781873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine Profiles Associated With Worse Prognosis in a Hospitalized Peruvian COVID-19 Cohort.
    Pons MJ; Ymaña B; Mayanga-Herrera A; Sáenz Y; Alvarez-Erviti L; Tapia-Rojas S; Gamarra R; Blanco AB; Moncunill G; Ugarte-Gil MF
    Front Immunol; 2021; 12():700921. PubMed ID: 34539631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiplex array analysis of circulating cytokines and chemokines in COVID-19 patients during the first wave of the SARS-CoV-2 pandemic in Milan, Italy.
    Calvo-Alvarez E; D'Alessandro S; Zanotta N; Basilico N; Parapini S; Signorini L; Perego F; Maina KK; Ferrante P; Modenese A; Pizzocri P; Ronsivalle A; Delbue S; Comar M
    BMC Immunol; 2024 Jul; 25(1):49. PubMed ID: 39061002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum Cytokine and Chemokine Profile in Relation to the Severity of Coronavirus Disease 2019 in China.
    Chi Y; Ge Y; Wu B; Zhang W; Wu T; Wen T; Liu J; Guo X; Huang C; Jiao Y; Zhu F; Zhu B; Cui L
    J Infect Dis; 2020 Aug; 222(5):746-754. PubMed ID: 32563194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal Cytokine Profile in Patients With Mild to Critical COVID-19.
    Ling L; Chen Z; Lui G; Wong CK; Wong WT; Ng RWY; Tso EYK; Fung KSC; Chan V; Yeung ACM; Hui DSC; Chan PKS
    Front Immunol; 2021; 12():763292. PubMed ID: 34938289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine/Chemokine Expression Is Closely Associated Disease Severity of Human Adenovirus Infections in Immunocompetent Adults and Predicts Disease Progression.
    Li J; Wei J; Xu Z; Jiang C; Li M; Chen J; Li Y; Yang M; Gu Y; Wang F; Shu Y; Yang Y; Sun L; Liu Y
    Front Immunol; 2021; 12():691879. PubMed ID: 34163488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement Anaphylatoxins and Inflammatory Cytokines as Prognostic Markers for COVID-19 Severity and In-Hospital Mortality.
    Alosaimi B; Mubarak A; Hamed ME; Almutairi AZ; Alrashed AA; AlJuryyan A; Enani M; Alenzi FQ; Alturaiki W
    Front Immunol; 2021; 12():668725. PubMed ID: 34276659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis of SARS-CoV-2 infection in the setting of the cytokine release syndrome.
    Azar MM; Shin JJ; Kang I; Landry M
    Expert Rev Mol Diagn; 2020 Nov; 20(11):1087-1097. PubMed ID: 32990479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-cohort study on cytokine and chemokine profiles in the progression of COVID-19.
    Huang C; Hu X; Wang D; Gong R; Wang Q; Ren F; Wu Y; Chen J; Xiong X; Li H; Wang Q; Long G; Zhang D; Han Y
    Sci Rep; 2024 May; 14(1):10324. PubMed ID: 38710800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 nucleocapsid protein, rather than spike protein, triggers a cytokine storm originating from lung epithelial cells in patients with COVID-19.
    Wang YC; Tsai CH; Wang YC; Yen LC; Chang YW; Sun JR; Lin TY; Chiu CH; Chao YC; Chang FY
    Infection; 2024 Jun; 52(3):955-983. PubMed ID: 38133713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine profiling in Iranian patients with COVID-19; association with clinical severity.
    Taghiloo S; Soltanshahi M; Aliyali M; Abedi S; Mehravaran H; Ajami A; Asgarian-Omran H
    Iran J Immunol; 2021 Mar; 18(1):54-64. PubMed ID: 33787514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine profiles of mild-to-moderate SARS-CoV-2 infected and recovered pre-vaccinated individuals residing in Indonesia.
    Megasari NLA; Khairunisa SQ; Arizandy RY; Wijaksana IKE; Wungu CDK
    PeerJ; 2024; 12():e17257. PubMed ID: 38646483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokine Profiles Before and After Immune Modulation in Hospitalized Patients with COVID-19.
    Azmy V; Kaman K; Tang D; Zhao H; Dela Cruz C; Topal JE; Malinis M; Price CC
    J Clin Immunol; 2021 May; 41(4):738-747. PubMed ID: 33459964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of cytokine/chemokine responses for the disease severity and management in children and adult cases with COVID-19.
    Ozsurekci Y; Aykac K; Er AG; Halacli B; Arasli M; Oygar PD; Gürlevik S; Cura Yayla BC; Karakaya J; Alp A; Topeli A; Cengiz AB; Akova M; Ceyhan M
    J Med Virol; 2021 May; 93(5):2828-2837. PubMed ID: 33225509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma biomarker profiling of PIMS-TS, COVID-19 and SARS-CoV2 seropositive children - a cross-sectional observational study from southern India.
    Venkataraman A; Kumar NP; Hanna LE; Putlibai S; Karthick M; Rajamanikam A; Sadasivam K; Sundaram B; Babu S
    EBioMedicine; 2021 Apr; 66():103317. PubMed ID: 33813138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interplay of Antibody and Cytokine Production Reveals CXCL13 as a Potential Novel Biomarker of Lethal SARS-CoV-2 Infection.
    Horspool AM; Kieffer T; Russ BP; DeJong MA; Wolf MA; Karakiozis JM; Hickey BJ; Fagone P; Tacker DH; Bevere JR; Martinez I; Barbier M; Perrotta PL; Damron FH
    mSphere; 2021 Jan; 6(1):. PubMed ID: 33472985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokine Signature Associated With Disease Severity in COVID-19.
    Guo J; Wang S; Xia H; Shi D; Chen Y; Zheng S; Chen Y; Gao H; Guo F; Ji Z; Huang C; Luo R; Zhang Y; Zuo J; Chen Y; Xu Y; Xia J; Zhu C; Xu X; Qiu Y; Sheng J; Xu K; Li L
    Front Immunol; 2021; 12():681516. PubMed ID: 34489933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different Profiles of Antibodies and Cytokines Were Found Between Severe and Moderate COVID-19 Patients.
    Guo Y; Li T; Xia X; Su B; Li H; Feng Y; Han J; Wang X; Jia L; Bao Z; Li J; Liu Y; Li L
    Front Immunol; 2021; 12():723585. PubMed ID: 34489974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of immune mediators in predicting hospitalization of SARS-CoV-2 positive patients.
    Ashrafzadeh-Kian S; Campbell MR; Jara Aguirre JC; Walsh J; Kumanovics A; Jenkinson G; Rinaldo P; Snyder MR; Algeciras-Schimnich A
    Cytokine; 2022 Feb; 150():155790. PubMed ID: 34991059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Galectin-9, a Player in Cytokine Release Syndrome and a Surrogate Diagnostic Biomarker in SARS-CoV-2 Infection.
    Bozorgmehr N; Mashhouri S; Perez Rosero E; Xu L; Shahbaz S; Sligl W; Osman M; Kutsogiannis DJ; MacIntyre E; O'Neil CR; Elahi S
    mBio; 2021 May; 12(3):. PubMed ID: 33947753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.